Daniel Abran
4Patents
2h-index
4Co-inventors
30Inventor score
Filing activity: Mar 27, 2003 → Jan 7, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6864239B2 | Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions | Physics | 9 | Expired |
| US7094761B2 | Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions | Physics | 9 | Expired |
| US7414029B2 | Antagonistic peptides of prostaglandin E2 receptor subtype EP4 | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7538185B2 | Glucagon-like peptide-1 analogs with long duration of action | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.